Company: AIBT
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001096906-25-001895
Chunk: 28

Company: AIBOTICS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 8
Chunk 28
---
 at September 30, 2024

666,666

1.50

0.30

Warrants outstanding at December 31, 2024

166,667

1.50

0.06

Granted

-

-

-

Exercised

-

-

-

Forfeited/Expired

 (166,667)

1.50

-

Warrants outstanding and exercisable at September 30, 2025

-

$
-

-

There were no outstanding warrants as of September 30, 2025.

NOTE 9 – COMMITMENTS AND CONTINGENCIES
 
On November 17, 2021, the Company entered into an Executive Consulting Agreement (the “Agreement”) with Benjamin Kaplan whereby Mr. Kaplan was appointed as CEO of the Company (see Note 5 – Related Party Transactions).

16

NOTE 10 – SUBSEQUENT EVENTS 
 
The company’s management has evaluated subsequent events occurring after September 30, 2025, the date of our most recent balance sheet, through the date our financial statements were issued.
 
Subsequent to the nine months ended September 30, 2025, the Company converted $10,700 of accrued interest into 2,675,000 shares of the Company’s common stock 
 
Subsequent to the nine months ended September 30, 2025, the Company converted $123,130 of accounts payable and accrued expenses into 41,043,702 shares of the Company’s common stock
 
Subsequent to the nine months ended September 30, 2025, the Company issued 34,364,713 shares of its common stock in exchange for total consideration of $103,093, consisting of $47,546 in cash proceeds, the settlement of $51,546 of accrued interest, and the settlement of $4,000 of equity issuance costs.

17

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read together with our financial statements and the related notes and the other financial information included elsewhere in this Quarterly Report. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Quarterly Report, particularly those under “Risk Factors.”

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report on Form 10-Q contains